Professor of Medicine
Division Of Digestive Diseases is a health wellness and fitness company based out of 410 W 10th Ave, Columbus, Ohio, United States.
Robert Baiocchi, MD, PhD joined the faculty at The Ohio State University in 2005 and is currently a fully tenured Professor of Internal Medicine, a member of the Leukemia Program of the Comprehensive Cancer Center and Associate Division Director in the Division of Hematology. Dr. Baiocchi leads the Division of Hematology’s Mentorship Program, the Physician Scientist Training Program and serves as Associate Residency Program Director for Research in the Department of Internal Medicine. He also serves as the institutional PI for the NIH AIDS Malignancy Consortium. Dr. Baiocchi’s clinical activities are focused on developing and delivering clinical trials to care for patients with immune deficiency and cancer (transplant, HIV/AIDS), immune dysregulation/autoinflammatory disorders (HLH, MAS), and histiocytic disorders (LCH, ECD, RDD). Dr. Baiocchi’s laboratory focuses on three major areas: (1) epigenetics of B-cell transformation; (2) experimental therapeutics of cancer and (3) immune surveillance of cancer with a particular focus on EBV-associated disease. He has over 20 years of experience investigating the pathogenesis of EBV-driven diseases and experimental therapeutics of lymphoma. Currently he is focused on translational strategies to develop a first-in-class vaccine to prevent EBV-driven diseases in high risk patients (solid organ transplant, BMT); experimental therapeutic strategies to target the epigenome, and immune reconstitution in HIV+ patients following stem cell transplantation. His research group has developed novel, first-in-class small molecule inhibitors of the PRMT5 enzyme to treat patients with hematologic and solid tumors. He actively collaborates with both local and national investigators on basic, translational and clinical research projects. Dr. Baiocchi’s translational research laboratory program has expertise in molecular genetics/virology, epigenetics, molecular and cellular immunology, preclinical animal models for human malignancy, and development of novel experimental therapeutic approaches to treat cancer. He has worked with the OSU Drug Development Institute and with industry partners to translate novel strategies to prevent and treat cancer from the lab into phase I clinical trials. His laboratory is fully funded by the NIH/NCI, American Cancer Society, and the Leukemia Lymphoma Society.
Anymail finder is trusted by tens of thousands of companies to provide accurate contact information to their Sales and Business Development teams.
If you’re looking to find the email of Robert Baiocchi at TOSUMC then you’ve come to the right place.
Wondering if it's robert@osumc.edu, robert.baiocchi@osumc.edu, baiocchi@osumc.edu, or rbaiocchi@osumc.edu? We have the answers for you.